Seafood-Derived Omega-3 Fatty Acids and Cardiovascular Disease Prevention: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
Abstract
Cardiovascular disease (CVD) remains the leading cause of death globally, representing 32 % of all deaths and necessitating effective preventive strategies. Despite widespread interest in omega-3 fatty acids for cardiovascular protection, conflicting evidence from randomized trials has created uncertainty regarding optimal formulations (EPA vs. EPA+DHA), efficacy, and risk-benefit profiles. This systematic review addresses critical knowledge gaps by synthesizing randomized controlled trial (RCT) evidence through 2024, providing formulation-specific comparison between EPA monotherapy and EPA+DHA combinations, as well as integrating comprehensive atrial fibrillation risk assessment. We searched EMBASE, PubMed, Cochrane Library, and ClinicalTrials.gov through August 2024 using comprehensive Boolean search strategies, identifying 38 RCTs involving 149,051 participants. Two independent reviewers performed both study selection and data extraction work. The researchers used the Cochrane Risk of Bias 2 tool to determine the risk of bias assessment. The meta-analysis used random-effects models to measure statistical diversity through I² statistics. GRADE methodology evaluated certainty of evidence. Omega-3 supplementation significantly reduced cardiovascular mortality (RR 0.93, 95 % CI: 0.88-0.98; moderate certainty evidence), non-fatal myocardial infarction (RR 0.87, 95 % CI: 0.81-0.93; moderate certainty), coronary heart disease events (RR 0.91, 95 % CI: 0.87-0.96; moderate…
How strong is the evidence?
Evidence Hub reads this as a meta-analysis, done in people. Its evidence level is 1 of 5 (Highest · pooled evidence). Pooled evidence from several studies sits at the top of the evidence pyramid. Reported size: 149,051 participants or records.
Read the paper
Related studies
- Promising Sources of Plant-Derived Polyunsaturated Fatty Acids: A Narrative Review
- Effects of omega-3 polyunsaturated fatty acid intake in patients with chronic kidney disease: Systematic review and meta-analysis of randomized controlled trials
- Effect of omega-3 fatty acids on cognition: an updated systematic review of randomized clinical trials
- The role of omega-3 polyunsaturated fatty acid supplementation in the management of type 2 diabetes mellitus: A narrative review
- Paucity of evidence for a relationship between long-chain omega-3 fatty acid intake and chronic obstructive pulmonary disease: a systematic review
- Omega-3 fatty acid nanocarriers: Characterization and potential applications
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.